查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026746

兒童神經病學醫療設備市場預測至2034年－按產品類型、疾病、年齡層、服務與療法、神經科亞專科、最終用戶和地區分類的全球分析

Pediatric Neurology Devices Market Forecasts to 2034 - Global Analysis By Product Type, Condition, Age Group, Service and Treatment, Neurological Subspecialties, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，到 2026 年，全球兒童神經醫療設備市場規模將達到 43 億美元，預計在預測期內將以 9.8% 的複合年成長率成長，到 2034 年達到 92 億美元。

專門用於診斷、觀察和治療兒童神經系統疾病的醫療設備稱為兒童神經科器械。這些器械用於治療癲癇、腦性麻痹和發育遲緩等疾病，包括腦電圖儀（EEG）、兒童磁振造影儀和復健CT掃描儀等各種儀器。

根據偏頭痛研究基金會的一份報告，一半的偏頭痛患者在 12 歲之前就會經歷第一次發作，甚至有報導稱，年僅 18 個月的嬰兒也患有偏頭痛。

政府項目和計劃的需求不斷成長

政府透過支持先進診斷和治療設備的研發，為兒童神經病學領域提供資金支持，促進團隊合作，激發創新精神，最終改善患者的治療效果。此外，這些努力也提高了人們對兒童神經系統疾病和專科護理重要性的認知。因此，只要政府繼續優先發展兒童醫學和研發，兒童神經病學設備就會持續發展創新，進而推動市場成長。

高成本

開發和製造兒童神經科專用設備通常需要大量的研究，並產生高昂的成本。這些高成本導致設備價格虛高，使許多患者和醫療機構難以負擔。醫療系統面臨的經濟負擔將限制其投資於兒童神經科治療領域最新技術和進展的能力。此外，病患、醫療機構和醫療系統可能面臨的經濟負擔也是兒童神經科醫療設備業高定價的主要弊端之一。

技術進步

醫療技術的持續創新正推動著更有效、創傷更小的醫療設備的研發，用於診斷、監測和治療兒童神經系統疾病。這些進步包括先進的神經影像技術、神經刺激設備和手術器械，這些技術提高了手術的精確度和安全性。此外，這些創新也透過為醫療專業人員提供日益精密的工具，改善了患者的治療效果，減輕了治療帶來的不適，並提高了兒童患者的生活品質，從而推動了市場擴張。

意識水平低

兒童神經系統設備的普及和使用有限是一項重大挑戰，其根源在於人們對這些設備的了解不足。患者、看護者和醫療專業人員可能並未充分了解所有可用的技術及其潛在益處。此外，這可能導致兒童神經系統設備被忽視或延遲使用，最終影響患者的治療。認知度低會減緩該領域的創新和研究步伐，並可能阻礙市場成長。

新冠疫情的感染疾病

新冠疫情兒童神經醫療設備市場造成了負面影響，主要原因是醫療系統中斷和經濟不確定性。封鎖和限制措施減少了擇期手術和非緊急就診，影響了兒童神經系統疾病的診斷和治療。此外，醫療系統面臨的財政負擔和病患數量的減少也影響了新設備和技術的應用。

在預測期內，神經外科醫療設備領域預計將成為最大的細分市場。

由於兒童神經外科醫療設備領域擁有專為治療兒童神經系統疾病而設計的各種手術器械和設備，預計該領域將佔據最大的市場佔有率。這些器械種類繁多，包括兒童專用神經科學用內視鏡、顱骨固定裝置、微創神經外科器械以及用於治療腦水腦症和先天性畸形等疾病的患者客製化植入。此外，這些器械的設計旨在滿足兒童患者特定的解剖和發育需求，使神經外科醫生能夠進行精準安全的治療，從而推動了該領域的成長。

預計在預測期內，癲癇發作細分市場將呈現最高的複合年成長率。

兒童癲癇發病率的不斷上升以及創新醫療設備的進步預計將推動癲癇發作治療領域在預測期內實現最高的複合年成長率。這包括用於監測腦部活動的腦電圖（EEG）、抗癲癇藥物、神經刺激設備（例如迷走神經刺激設備器）以及癲癇發作警報器。此外，該領域專注於用於診斷、監測和治療兒童癲癇發作的醫療設備，這對於兒童癲癇的治療至關重要，因此也是推動該領域成長的主要因素。

市佔率最大的地區：

在預測期內，北美佔據了最大的市場佔有率。遠端醫療的普及正在更廣泛地擴大兒童神經科服務的覆蓋範圍。神經影像學和腦電圖（EEG）技術的最新進展包括更小巧、更適合兒童使用的設備，使檢查更加準確，也更便於兒童接受。在美國、加拿大和墨西哥等國家，神經刺激技術和數據分析技術的進步，提高了數據解讀能力，從而改善了癲癇等疾病的治療選擇，推動了該地區的成長。

複合年成長率最高的地區：

由於歐洲藥品管理局 (EMA) 和各國衛生機構等監管機構對醫療設備實施了嚴格的安全性和有效性標準，預計歐洲在預測期內將實現最高的複合年成長率 (CAGR)。Medtronic力公司、雅培公司、西門子醫療公司和波士頓科學公司等領導企業正致力於開發和推廣專為兒童設計的先進診斷工具、治療設備和監控解決方案。此外，許多歐洲國家將這些設備納入醫療保險和公共醫療保健計劃的覆蓋範圍，也推動了該地區的市場擴張。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球兒童神經病學醫療設備市場：依產品類型分類

  • 神經外科醫療設備
  • 腦脊髓液管理裝置
  • 神經刺激裝置
  • 介入性神經學用醫療設備
  • 其他產品類型

第6章 全球兒童神經病學醫療設備市場：依疾病分類

  • 發作
  • 中風
  • 水腦症
  • 腫瘤學
  • 其他疾病

第7章 全球兒童神經病學醫療設備市場：依年齡層別分類

  • 0-5歲
  • 5-10歲
  • 10-15歲

第8章 全球兒童神經病學醫療設備市場：按服務和治療類型分類

  • 鞘內注射Baclofen療法
  • 迷走神經刺激療法
  • 腦電圖（EEG）
  • 神經系統評估
  • 其他服務和治療

第9章 全球兒童神經病學醫療設備市場：依神經科亞專科分類

  • 神經肌肉
  • 神經免疫學
  • 神經腫瘤學
  • 新生兒神經病學

第10章 全球兒童神經病學醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 其他最終用戶

第11章 全球兒童神經病學醫療設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第12章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：公司簡介

  • Medtronic
  • Elana, Inc.
  • Stryker Corporation
  • Inova Healthcare System
  • Boston Scientific Corporation
  • The Nemours Foundation
  • Integra LifeSciences Corporation
  • B.Braun Melsungen AG
  • Abbott Laboratories
  • St. Jude Medical, LLC
  • Zimmer Biomet Holding Inc.
  • LivaNova PLC
  • Natus Medical Incorporated
  • Karl Storz SE & Co. KG
Product Code: SMRC24606

According to Stratistics MRC, the Global Pediatric Neurology Devices Market is accounted for $4.3 billion in 2026 and is expected to reach $9.2 billion by 2034 growing at a CAGR of 9.8% during the forecast period. Medical equipment made especially for the diagnosis, observation, and treatment of neurological diseases in children is known as pediatric neurology equipment. These devices treat disorders including epilepsy, cerebral palsy, and developmental delays, which include a variety of instruments such as electroencephalography (EEG) machines, pediatric MRIs, and CT scanners for rehabilitation.

According to the Migraine Research Foundation report, it has been observed that half of all migraine sufferers have their first attack before the age of 12 and migraine has even been reported to in 18 months old children.

Market Dynamics:

Driver:

Rising demand in government programs and projects

The government initiatives provide funds, encourage teamwork, and foster creativity in the field of pediatric neurology by supporting the development of advanced diagnostic and treatment devices, ultimately improving patient outcomes. Additionally, such initiatives raise awareness about pediatric neurological disorders and the importance of specialized care. Therefore, pediatric neurology devices will continue to develop and innovate as long as governments continue to place a high priority on pediatric healthcare and research, which are driving this market's growth.

Restraint:

High cost

The development and production of specialized pediatric neurology devices often involve extensive research, leading to substantial costs. These high costs can result in inflated prices for devices, making them unaffordable for many patients and healthcare providers. The financial strain on healthcare systems can limit their ability to invest in the latest technologies and advancements in pediatric neurology treatment. Additionally, the possible financial strain on patients, healthcare providers, and healthcare systems is one major drawback of the high pricing in the pediatric neurology device industry.

Opportunity:

Technological advancements

The ongoing innovation in medical technology leads to the development of more effective and minimally invasive devices for diagnosing, monitoring, and treating pediatric neurological disorders. This progress includes advanced neuroimaging techniques, neurostimulation devices, and surgical tools that enhance the precision and safety procedures. Furthermore, these innovations improve patient outcomes, reduce treatment-related discomfort, and contribute to a better quality of life for pediatric patients by providing healthcare professionals with increasingly sophisticated tools, which is boosting this market expansion.

Threat:

Lack of awareness

The restricted adoption and utilization of pediatric neurology equipment is a significant drawback resulting from a lack of understanding. Patients, caregivers, and healthcare professionals may not be aware of all the technologies that are available or all of their potential advantages. In addition, this may result in pediatric neurology equipment being neglected or adopted more slowly, which would ultimately affect patient treatment. The lack of awareness may contribute to a slower pace of innovation and research in the field, thereby impeding this market size.

Covid-19 Impact

The COVID-19 pandemic has had negative impacts on the pediatric neurology device market, primarily due to disruptions in healthcare systems and economic uncertainties. Lockdowns and restrictions led to a reduction in elective procedures and non-urgent medical appointments, affecting the diagnosis and treatment of pediatric neurological conditions. The adoption of new gadgets and technology was also impacted by the financial strains placed on healthcare systems and the decline in patient visits.

The neurosurgery devices segment is expected to be the largest during the forecast period

The neurosurgery devices segment is estimated to hold the largest share due to surgical instruments and equipment specifically made for treating neurological problems in children. This covers a broad spectrum of devices, including pediatric-sized neuroendoscopes, cranial fixation devices, minimally invasive neurosurgical instruments, and patient-specific implants for ailments such as hydrocephalus and congenital abnormalities. Additionally, these enable neurosurgeons to carry out accurate and secure treatments as they are designed with the special anatomical and developmental needs of pediatric patients, which are driving this segment's growth.

The seizures segment is expected to have the highest CAGR during the forecast period

The seizures segment is anticipated to have highest CAGR during the forecast period due to the increasing prevalence of pediatric epilepsy and the ongoing development of innovative devices. This includes electroencephalography (EEG) machines for monitoring brain activity, anti-seizure medications, neurostimulation devices like vagus nerve stimulators, and seizure alarms. Furthermore, it focuses on devices designed to diagnose, monitor, and treat seizures in pediatric patients and are crucial in the management of pediatric epilepsy which are thereby boosting this segment's expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period. Pediatric neurology services are now more widely accessible due to the rise in popularity of telemedicine alternatives. New developments in the field of neuroimaging and EEG include smaller, more kid-friendly equipment that makes examinations of children more accurate and comfortable. Countries such as the United States, Canada, and Mexico have improved therapy options for diseases like epilepsy due to developments in neurostimulation techniques and data analytics to improve data interpretation, which are propelling this region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to the regulatory organizations like the European Medicines Agency (EMA) and national health agencies which impose strict safety and efficacy standards for these devices. Major Key players such as Medtronic plc, Abbott Laboratories, Siemens Healthineers and Boston Scientific Corporation contribute to development and adoption of sophisticated diagnostic tools, therapeutic devices, and monitoring solutions tailored specifically for children. Furthermore, the cost of these devices is frequently covered by health insurance and public healthcare systems in many European nations which are driving this region's expansion.

Key players in the market

Some of the key players in the Pediatric Neurology Devices Market include Medtronic, Elana, Inc., Stryker Corporation, Inova Healthcare System, Boston Scientific Corporation, The Nemours Foundation, Integra LifeSciences Corporation, B.Braun Melsungen AG, Abbott Laboratories, St. Jude Medical, LLC, Zimmer Biomet Holding Inc., LivaNova PLC, Natus Medical Incorporated and Karl Storz SE & Co. KG.

Key Developments:

In October 2023, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha(TM) Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body.

In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept(R) Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

In June 2023, Amcor the American Diabetes Association(R) and Abbott announced collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.

In March 2023, Somatus, the nation's leading and largest value-based kidney Care Company, and Inova Health System announce the new Nurse Navigator Program launch, an innovative addition to the already successful partnership.

Product Types Covered:

  • Neurosurgery Devices
  • Cerebrospinal Fluid Management Devices
  • Neurostimulation Devices
  • Interventional Neurology Devices
  • Other Product Types

Conditions Covered:

  • Seizures
  • Stroke
  • Hydrocephalus
  • Oncology
  • Other Conditions

Age Group Covered:

  • 0-5 Years
  • 5-10 Years
  • 10-15 Years

Service and Treatments Covered:

  • Intrathecal baclofen therapy
  • Vagal nerve stimulation
  • Electroencephalogram
  • Neurological Evaluations
  • Other Service and Treatments

Neurological Subspecialties Covered:

  • Neuromuscular
  • Neuroimmunology
  • Neuro-oncology
  • Neonatal Neurology

End Users Covered:

  • Ambulatory surgery centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pediatric Neurology Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Neurosurgery Devices
  • 5.3 Cerebrospinal Fluid Management Devices
  • 5.4 Neurostimulation Devices
  • 5.5 Interventional Neurology Devices
  • 5.6 Other Product Types

6 Global Pediatric Neurology Devices Market, By Condition

  • 6.1 Introduction
  • 6.2 Seizures
  • 6.3 Stroke
  • 6.4 Hydrocephalus
  • 6.5 Oncology
  • 6.6 Other Conditions

7 Global Pediatric Neurology Devices Market, By Age Group

  • 7.1 Introduction
  • 7.2 0-5 Years
  • 7.3 5-10 Years
  • 7.4 10-15 Years

8 Global Pediatric Neurology Devices Market, By Service and Treatment

  • 8.1 Introduction
  • 8.2 Intrathecal baclofen therapy
  • 8.3 Vagal nerve stimulation
  • 8.4 Electroencephalogram
  • 8.5 Neurological Evaluations
  • 8.6 Other Service and Treatments

9 Global Pediatric Neurology Devices Market, By Neurological Subspecialties

  • 9.1 Introduction
  • 9.2 Neuromuscular
  • 9.3 Neuroimmunology
  • 9.4 Neuro-oncology
  • 9.5 Neonatal Neurology

10 Global Pediatric Neurology Devices Market, By End User

  • 10.1 Introduction
  • 10.2 Ambulatory surgery centers
  • 10.3 Hospitals
  • 10.4 Other End Users

11 Global Pediatric Neurology Devices Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Medtronic
  • 13.2 Elana, Inc.
  • 13.3 Stryker Corporation
  • 13.4 Inova Healthcare System
  • 13.5 Boston Scientific Corporation
  • 13.6 The Nemours Foundation
  • 13.7 Integra LifeSciences Corporation
  • 13.8 B.Braun Melsungen AG
  • 13.9 Abbott Laboratories
  • 13.10 St. Jude Medical, LLC
  • 13.11 Zimmer Biomet Holding Inc.
  • 13.12 LivaNova PLC
  • 13.13 Natus Medical Incorporated
  • 13.14 Karl Storz SE & Co. KG

List of Tables

  • Table 1 Global Pediatric Neurology Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pediatric Neurology Devices Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Pediatric Neurology Devices Market Outlook, By Neurosurgery Devices (2023-2034) ($MN)
  • Table 4 Global Pediatric Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2023-2034) ($MN)
  • Table 5 Global Pediatric Neurology Devices Market Outlook, By Neurostimulation Devices (2023-2034) ($MN)
  • Table 6 Global Pediatric Neurology Devices Market Outlook, By Interventional Neurology Devices (2023-2034) ($MN)
  • Table 7 Global Pediatric Neurology Devices Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 8 Global Pediatric Neurology Devices Market Outlook, By Condition (2023-2034) ($MN)
  • Table 9 Global Pediatric Neurology Devices Market Outlook, By Seizures (2023-2034) ($MN)
  • Table 10 Global Pediatric Neurology Devices Market Outlook, By Stroke (2023-2034) ($MN)
  • Table 11 Global Pediatric Neurology Devices Market Outlook, By Hydrocephalus (2023-2034) ($MN)
  • Table 12 Global Pediatric Neurology Devices Market Outlook, By Oncology (2023-2034) ($MN)
  • Table 13 Global Pediatric Neurology Devices Market Outlook, By Other Conditions (2023-2034) ($MN)
  • Table 14 Global Pediatric Neurology Devices Market Outlook, By Age Group (2023-2034) ($MN)
  • Table 15 Global Pediatric Neurology Devices Market Outlook, By 0-5 Years (2023-2034) ($MN)
  • Table 16 Global Pediatric Neurology Devices Market Outlook, By 5-10 Years (2023-2034) ($MN)
  • Table 17 Global Pediatric Neurology Devices Market Outlook, By 10-15 Years (2023-2034) ($MN)
  • Table 18 Global Pediatric Neurology Devices Market Outlook, By Service and Treatment (2023-2034) ($MN)
  • Table 19 Global Pediatric Neurology Devices Market Outlook, By Intrathecal baclofen therapy (2023-2034) ($MN)
  • Table 20 Global Pediatric Neurology Devices Market Outlook, By Vagal nerve stimulation (2023-2034) ($MN)
  • Table 21 Global Pediatric Neurology Devices Market Outlook, By Electroencephalogram (2023-2034) ($MN)
  • Table 22 Global Pediatric Neurology Devices Market Outlook, By Neurological Evaluations (2023-2034) ($MN)
  • Table 23 Global Pediatric Neurology Devices Market Outlook, By Other Service and Treatments (2023-2034) ($MN)
  • Table 24 Global Pediatric Neurology Devices Market Outlook, By Neurological Subspecialties (2023-2034) ($MN)
  • Table 25 Global Pediatric Neurology Devices Market Outlook, By Neuromuscular (2023-2034) ($MN)
  • Table 26 Global Pediatric Neurology Devices Market Outlook, By Neuroimmunology (2023-2034) ($MN)
  • Table 27 Global Pediatric Neurology Devices Market Outlook, By Neuro-oncology (2023-2034) ($MN)
  • Table 28 Global Pediatric Neurology Devices Market Outlook, By Neonatal Neurology (2023-2034) ($MN)
  • Table 29 Global Pediatric Neurology Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 30 Global Pediatric Neurology Devices Market Outlook, By Ambulatory surgery centers (2023-2034) ($MN)
  • Table 31 Global Pediatric Neurology Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 32 Global Pediatric Neurology Devices Market Outlook, By Other End Users (2023-2034) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.